Navigation Links
Smart Drug Development for Better Patient Treatment – Advancements Television Series

Advancements with Ted Danson will focus on recent developments in life science and drug development. This episode is scheduled to broadcast 4Q/2019. Check local listings for more information.

This segment of Advancements will explore Debiopharm, a biopharmaceutical research, development, investment and manufacturing company. The show will highlight how Debiopharm is working to champion the synergy between therapeutic and artificial intelligence (AI) innovation in the fight against cancer.

“Pharmaceutical companies can no longer afford to focus on drug development alone,” explained Mr. Thierry Mauvernay, President of Debiopharm. “We see that the healthcare of tomorrow needs to encompass the overall patient journey, from diagnosis, through personalized treatment and monitoring in order to truly respond to patients’ overall needs.”

Debiopharm’s pipeline includes a range of oncology therapies based on novel approaches to fight against disease including its chemo-radio-sensitizer treatment, which works by preventing cancer cells from evading the cell death process caused by chemo-radiotherapy and by improving anti-tumor immunity. Ongoing research also includes an FGFR Inhibitor, which targets cancers with specific genetic alterations of this cell receptor, regardless of the tumor type, currently in development along with a companion genetic diagnostic tool. Beyond therapeutics, the company has a strategic role in the development of smart healthcare technologies based on data and AI to improve treatment efficiency and ultimately patient quality of life.

“We’ve now arrived at a time in which smart digital companions to therapeutic approaches are actually making a real difference for the health of patients” stated Tanja Dowe, CEO Debiopharm Innovation Fund. “We believe that by remaining flexible, dynamic, and open to the emerging need for more ‘agile medicine,’ we will have a measurable impact on the future of patient healthcare.”

About Debiopharm
Debiopharm aims to develop innovative therapies that target high unmet medical needs in oncology and bacterial infections. Bridging-the-gap between disruptive discovery products and real-world patient reach, the company identifies high-potential compounds for in-licensing, clinically demonstrates their safety and efficacy, and then selects large pharmaceutical commercialization partners to maximize patient access globally.
For more information, visit / or follow @DebiopharmNews at

About Advancements and DMG Productions:
The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit or call Richard Lubin at 866-496-4065.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. $1 million for smart energy solutions
2. Survey of physicians suggests tablets more useful than smartphones
3. AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life
4. Healthrageous, United BioSource And Boehringer Ingelheim Launch SMART Digital Diabetes Study
5. Frost & Sullivan: Moving the Smart Cities Idea from Concept to Reality
6. SmartMove, Inc. receives $200,000 grant from the Colorado Office of Economic Development and International Trade
7. FPC Awarded new Smartphone DW From Existing Prominent Asian OEM Customer for Launch With Leading US Operator
8. Researchers use smart phone photography to diagnose eye disease
9. Improved smartphone microscope brings single-virus detection to remote locations
10. National Robotics Initiative grant to create smarter surgical robots
11. Fujitsu Launches Four Smartphones and Two Tablet PCs With FPC Embedded Fingerprint Technology for the Japanese Market
Post Your Comments:
(Date:9/8/2019)... , ... September 06, 2019 ... ... disrupter and leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing ... umbilical cord (hUC) MSC paired cell and media system designed for product ...
(Date:8/29/2019)... ... 2019 , ... Advancements with Ted Danson announced today that ... which is scheduled to broadcast 1Q/2020. Check local listings for more information. , ... solutions for the treatment of patients suffering from spinal disorders. Traveling behind-the-scenes to ...
(Date:8/27/2019)... ... August 26, 2019 , ... Shoreline Biome , a microbiome research company ... Bill McKenzie as its CEO and Karen Woodward as its VP of Business Development. ... demand for its products and expand the company’s sales worldwide. , Prior to joining ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... , ... Tucker, a Labrador retriever, was just a puppy when he began ... lame on his right hip and elbow. At one year of age, Tucker was ... the vet had seen.” He was prescribed pain medications, both oral and injectable, as ...
(Date:9/17/2019)... ... September 16, 2019 , ... A ... Saturday, September 21st @11:00am ET. Check local listings for more information on this ... Biomedical), a molecular diagnostic company from Singapore dedicated to developing advanced diagnostic technologies ...
(Date:9/11/2019)... (PRWEB) , ... September 10, 2019 , ... ... broadcast 1Q/2020 will educate about the latest developments in genome sequencing analysis. Check ... about the innovation taking place at Rivermap Research & Consulting and will explore ...
(Date:9/8/2019)... ... September 05, 2019 , ... ... former Vice President of Finance for Shopify, has been named Chief Financial Officer. ... venture capitalist Joel Finlayson as strategic advisors. Additionally, Spartan has hired Steve Edgett ...
Breaking Biology Technology: